← Open Payments lookup

SAMANTHA FOX: Open Payments

NPI 1023673407 · BRISTOL, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$143,905 in 367 payments from 13 companies in 2025. Trend: 2023 $1,100 · 2024 $61,679 · 2025 $143,905

Honoraria: $89,625Travel & lodging: $25,424Speaker / faculty: $21,000Food & beverage: $5,357Consulting: $2,500
CompanyPaymentsAmount
Axsome Therapeutics, Inc.223$114,290
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)62$26,065
ABBVIE INC.36$2,342
Alkermes, Inc.10$233
Supernus Pharmaceuticals, Inc.9$195
E.R. Squibb & Sons, L.L.C.6$190
Vanda Pharmaceuticals Inc.7$181
Neuronetics, Inc.1$121
Neurocrine BioSciences, Inc.4$100
Otsuka America Pharmaceutical, Inc.5$93

Products named: Auvelity, CAPLYTA, VRAYLAR, Qelbree, COBENFY, LYBALVI, FANAPT, NEUROSTAR TMS THERAPY SYSTEM.

Industry payments across VA — which companies pay providers there.